WallStreetZenWallStreetZen

NASDAQ: INKT
Mink Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Mink Therapeutics earnings were -$13.8M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest INKT earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$1.8M, down 33.1% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, INKT reported annual earnings of -$22.5M, with -19.8% growth.

INKT earnings history

Current Revenue
$0.0
Current Earnings
-$13.8M
Current Profit Margin
0%

INKT Return on Equity

Current Company
N/A
Current Industry
20.1%
Current Market
35.6%

INKT Return on Assets

Current Company
-189.1%
Current Industry
1.4%
INKT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when INKT announces earnings.

INKT Return on Capital Employed

Current Company
56,823.62%
Current Industry
14.3%
INKT has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

INKT vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
INKT-$13.57M-$13.78MN/A-$0.38
LPCN-$4.02M-$4.06MN/A-$0.74
CLDI-$24.36M-$27.95MN/A-$1.55
ENLV-$18.97M-$18.93MN/A-$0.98
EQ-$4.46M-$4.62MN/A-$0.13
View Top Biotech Stocks

Mink Therapeutics Earnings Reports & History FAQ

What were Mink Therapeutics's earnings last quarter?

Mink Therapeutics (NASDAQ: INKT) reported Q3 2024 earnings per share (EPS) of -$0.05, up 66.67% year over year. Total INKT earnings for the quarter were -$1.81 million. In the same quarter last year, Mink Therapeutics's earnings per share (EPS) was -$0.15.

If you're new to stock investing, here's how to buy Mink Therapeutics stock.

Is Mink Therapeutics profitable or losing money?

As of the last Mink Therapeutics earnings report, Mink Therapeutics is currently losing money. Mink Therapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$13.78 million, a 44.36% decrease year over year.

What was INKT's earnings growth in the past year?

As of Mink Therapeutics's earnings date in Q4 2024, Mink Therapeutics's earnings has grown year over year. INKT earnings in the past year totalled -$13.78 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.